Table of Contents

1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Neutral Alternative Protein Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Plant Protein
2.1.2 Insect Protein
2.1.3 Algae Protein
2.1.4 Others
2.2 Overall Market Performance(Value)
2.2.1 Plant Protein
2.2.2 Insect Protein
2.2.3 Algae Protein
2.2.4 Others
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Food & Beverage
3.1.2 Healthcare product
4 Manufacturers Profiles/Analysis
4.1 Kerry Group
4.1.1 Kerry Group Profiles
4.1.2 Kerry Group Product Information
4.1.3 Kerry Group Neutral Alternative Protein Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Kerry Group SWOT Analysis
4.2 Cargill
4.2.1 Cargill Profiles
4.2.2 Cargill Product Information
4.2.3 Cargill Neutral Alternative ProteinSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Cargill SWOT Analysis
4.3 Archer Daniels Midland Company
4.3.1 Archer Daniels Midland Company Profiles
4.3.2 Archer Daniels Midland Company Product Information
4.3.3 Archer Daniels Midland Company Neutral Alternative ProteinSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Archer Daniels Midland Company SWOT Analysis
4.4 Glanbia
4.4.1 Glanbia Profiles
4.4.2 Glanbia Product Information
4.4.3 Glanbia Neutral Alternative ProteinSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Glanbia SWOT Analysis
4.5 CHS
4.5.1 CHS Profiles
4.5.2 CHS Product Information
4.5.3 CHS Neutral Alternative ProteinSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 CHS SWOT Analysis
4.6 Tereos Syral
4.6.1 Tereos Syral Profiles
4.6.2 Tereos Syral Product Information
4.6.3 Tereos Syral Neutral Alternative ProteinSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Tereos Syral SWOT Analysis
4.7 CP Kelco
4.7.1 CP Kelco Profiles
4.7.2 CP Kelco Product Information
4.7.3 CP Kelco Neutral Alternative ProteinSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 CP Kelco SWOT Analysis
4.8 Davisco
4.8.1 Davisco Profiles
4.8.2 Davisco Product Information
4.8.3 Davisco Neutral Alternative ProteinSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Davisco SWOT Analysis
4.9 Meelunie
4.9.1 Meelunie Profiles
4.9.2 Meelunie Product Information
4.9.3 Meelunie Neutral Alternative ProteinSales, Sales Value (Million USD), Price and Gross Profit
4.9.4 Meelunie SWOT Analysis
4.10 Danisco (DuPont)
4.10.1 Danisco (DuPont) Profiles
4.10.2 Danisco (DuPont) Product Information
4.10.3 Danisco (DuPont) Neutral Alternative ProteinSales, Sales Value (Million USD), Price and Gross Profit
4.10.4 Danisco (DuPont) SWOT Analysis
4.11 MGP Ingredient
4.12 Taj Agro Product
4.13 Glico Nutrition
5 Market Performance for Manufacturers
5.1 Global Neutral Alternative Protein Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Neutral Alternative Protein Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Neutral Alternative Protein Market Assessment by Regions (2014-2020)
7.1 Global Neutral Alternative Protein Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Neutral Alternative Protein Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Neutral Alternative Protein Price (USD/Unit) by Regions 2014-2020
7.4 Global Neutral Alternative Protein Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Food & Beverage Industry
11.2 Healthcare product Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Neutral Alternative Protein Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Plant Protein
12.2.3 Insect Protein
12.2.4 Algae Protein
12.2.5 Others
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Food & Beverage
12.3.3 Healthcare product
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Neutral Alternative Protein Price (USD/Unit) Trend 2021-2026
12.4.2 Global Neutral Alternative Protein Gross Profit Trend 2021-2026
13 Conclusion